Insights

Loading spinner
Gathering insights about Acer Therapeutics Inc.

Similar companies to Acer Therapeutics Inc.

Acer Therapeutics Inc. Tech Stack

Acer Therapeutics Inc. uses 8 technology products and services including Cloudflare, MySQL, jQuery, and more. Explore Acer Therapeutics Inc.'s tech stack below.

  • Cloudflare
    Content Management System
  • MySQL
    Database
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • PHP
    Programming Languages
  • Apache
    Web Servers

Media & News

Acer Therapeutics Inc.'s Email Address Formats

Acer Therapeutics Inc. uses at least 1 format(s):
Acer Therapeutics Inc. Email FormatsExamplePercentage
FLast@acertx.comJDoe@acertx.com
82%
FirstLast@acertx.comJohnDoe@acertx.com
11%
First.Last@acertx.comJohn.Doe@acertx.com
4%
Last@acertx.comDoe@acertx.com
3%

Frequently Asked Questions

Where is Acer Therapeutics Inc.'s headquarters located?

Minus sign iconPlus sign icon
Acer Therapeutics Inc.'s main headquarters is located at 300 Washington St 351 Newton, Massachusetts 02458 US. The company has employees across 2 continents, including North AmericaAsia.

What is Acer Therapeutics Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Acer Therapeutics Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Acer Therapeutics Inc.'s stock symbol?

Minus sign iconPlus sign icon
Acer Therapeutics Inc. is a publicly traded company; the company's stock symbol is ACER.

What is Acer Therapeutics Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Acer Therapeutics Inc.'s official website is acertx.com and has social profiles on LinkedIn.

How much revenue does Acer Therapeutics Inc. generate?

Minus sign iconPlus sign icon
As of November 2024, Acer Therapeutics Inc.'s annual revenue reached $3.8M.

What is Acer Therapeutics Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Acer Therapeutics Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Acer Therapeutics Inc. have currently?

Minus sign iconPlus sign icon
As of November 2024, Acer Therapeutics Inc. has approximately 17 employees across 2 continents, including North AmericaAsia. Key team members include Chief People Officer: B. P.Chief Scientific Officer: D. H.Chief Legal Officer: D. J.. Explore Acer Therapeutics Inc.'s employee directory with LeadIQ.

What industry does Acer Therapeutics Inc. belong to?

Minus sign iconPlus sign icon
Acer Therapeutics Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Acer Therapeutics Inc. use?

Minus sign iconPlus sign icon
Acer Therapeutics Inc.'s tech stack includes CloudflareMySQLjQueryModernizrRSSOpen GraphPHPApache.

What is Acer Therapeutics Inc.'s email format?

Minus sign iconPlus sign icon
Acer Therapeutics Inc.'s email format typically follows the pattern of . Find more Acer Therapeutics Inc. email formats with LeadIQ.

How much funding has Acer Therapeutics Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2024, Acer Therapeutics Inc. has raised $1M in funding. The last funding round occurred on Jun 26, 2023 for $1M.

When was Acer Therapeutics Inc. founded?

Minus sign iconPlus sign icon
Acer Therapeutics Inc. was founded in 2013.
Acer Therapeutics Inc.

Acer Therapeutics Inc.

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

Acer Therapeutics Inc. (Nasdaq: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer’s pipeline includes four programs: ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); emetine hydrochloride, a host-directed therapy against a variety of infectious diseases, initially for the treatment of patients with COVID-19; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant for the treatment of induced Vasomotor Symptoms (iVMS). Each of Acer’s product candidates is believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Acer's strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. 

Acer has a strong company culture and is committed to creating and maintaining an environment that values individual rights, hard work, fosters creativity, and promotes success. The Company is growing and is fueled by the talent and expertise of our employees, driven by the commitment to treating patients with critical unmet medical needs.

Section iconCompany Overview

Headquarters
300 Washington St 351 Newton, Massachusetts 02458 US
Phone number
Website
acertx.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ACER
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $1M

    Acer Therapeutics Inc. has raised a total of $1M of funding over 7 rounds. Their latest funding round was raised on Jun 26, 2023 in the amount of $1M.

  • $10M

    Acer Therapeutics Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $1M

    Acer Therapeutics Inc. has raised a total of $1M of funding over 7 rounds. Their latest funding round was raised on Jun 26, 2023 in the amount of $1M.

  • $10M

    Acer Therapeutics Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.